Global Pneumonia Testing Market Overview:
Pneumonia Testing Market was valued at $945 million in 2016, and is predicted to reach $ 1,754.3 million by 2023, growth of at a CAGR of 9.4% during the forecast time period. Pneumonia is a complicated infection influencing reduce respiratory tract with symptoms that include short breathing, fever, chest pain, nausea, and thus vomiting. Regarding pneumonia, the air sacs of lungs called as alveoli, get filled with fluid or pus, leading to inflammation.
The condition is mainly stimulated due to micro-organisms such as bacteria, virus, fungi, as well as parasitic organisms and affecting people with weak immune system. The instance is quite common in children and perhaps older people. Based on WHO research studies, pneumonia is one of the main reasons for death among children it is estimated to have an affect on just about 1.2 million little children under the age of 5 years, annually. Relating to WHO, 95% of all pneumococcal episodes appear in children in the developing countries.
The demand for pain maintenance drugs in the nowadays is on the rise. POC testing is a new technology, which is certainly now an ideal approach that is utilized in detecting pneumonia.
The POC test is conducted from the comfort of one’s home to bedside diagnosis in hospitals. Improving attractiveness for POC tests within the health care sector would contribute the industry attractiveness during the expectation period. Researching and the development plans are growing for the development of more advanced PCR-based technologies which could be utilized for faster outcome.
Full Report: https://kbvresearch.com/pneumonia-testing-market/